1.Brook I., Frazier EH. Clinical and microbiological features of necrotizing fasciitis. J Clin Microbiol. 1995. 33:2382–7.
Article
2.Gardam MA., Low DE., Saginur R., Miller MA. Group B streptococcal necrotizing fasciitis and streptococcal toxic shock-like syndrome in adults. Arch Intern Med. 1998. 158:1704–8.
Article
3.Kihiczak GG., Schwartz RA., Kapila R. Necrotizing fasciitis: a deadly infection. J Eur Acad Dermatol Venereol. 2006. 20:365–9.
Article
4.Ceilley RI. Foot ulceration and vertebral osteomyelitis with Corynebacterium haemolyticum. Arch Dermatol. 1977. 113:646–7.
5.Chang K., Siu LK., Chen YH., Lu PL., Chen TC., Hsieh HC, et al. Fatal Pasteurella multocida septicemia and necrotizing fasciitis related with wound licked by a domestic dog. Scand J Infect Dis. 2007. 39:167–70.
6.Lipsky BA., Berendt AR., Deery HG., Embil JM., Joseph WS., Karchmer AW, et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2004. 39:885–910.
Article
7.Griego RD., Rosen T., Orengo IF., Wolf JE. Dog, cat, and human bites: a review. J Am Acad Dermatol. 1995. 33:1019–29.
Article
8.Douglas AK., Allen BK. Postoperative infections and antimicrobial prophylaxis. Gerald LM, John EB, editors. Principles and practice of infectious diseases. 4th ed.New York: Churchill Livingstone;1995. p. 2746.
9.Crum NF., Wallace MR. Group B streptococcal necrotizing fasciitis and toxic shock-like syndrome: a case report and review of the literature. Scand J Infect Dis. 2003. 35:878–81.
Article
10.Holmstrom B., Grimsley EW. Necrotizing fasciitis and toxic shock-like syndrome caused by group B Streptococcus. South Med J. 2000. 93:1096–8.
11.Carlson P., Korpela J., Walder M., Nyman M. Antimicrobial susceptibilities and biotypes of Arcanobacterium haemolyticum blood isolates. Eur J Clin Microbiol Infect Dis. 1999. 18:915–7.
12.Linder R. Rhodococcus equi and Arcanobacterium haemolyticum: two “coryneform” bacteria increasingly recognized as agents of human infection. Emerg Infect Dis. 1997. 3:145–53.
13.Yuli S., Sydney MF. Peptostreptococcus, Finegoldia, Anaerococcus, Peptoniphilus, Veillonella, and other anaerobic cocci. Murray PR, Baron EJ, editors. Manual of clinical microbiology. 9th ed.Washington: ASM Press;2007. p. 863.
14.Brook I. Aerobic and anaerobic microbiology of necrotizing fasciitis in children. Pediatr Dermatol. 1996. 13:281–4.
Article
15.Ge Y., MacDonald D., Henry MM., Hait HI., Nelson KA., Lipsky BA, et al. In vitro susceptibility to pexiganan of bacteria isolated from infected diabetic foot ulcers. Diagn Microbiol Infect Dis. 1999. 35:45–53.
Article
16.Yildirim AO., Lammler C., Weiss R., Kopp P. Pheno- and genotypic properties of streptococci of serological group B of canine and feline origin. FEMS Microbiol Lett. 2002. 212:187–92.
Article
17.Jobanputra RS., Swain CP. Septicaemia due to Corynebacterium haemolyticum. J Clin Pathol. 1975. 28:798–800.
18.Batty A., Wren MW. Prevalence of Fusobacterium necrophorum and other upper respiratory tract pathogens isolated from throat swabs. Br J Biomed Sci. 2005. 62:66–70.
19.DiPersio LP., DiPersio JR. High rates of erythromycin and clindamycin resistance among OBGYN isolates of group B Streptococcus. Diagn Microbiol Infect Dis. 2006. 54:79–82.